论文部分内容阅读
研究证实许多免疫分子在肾细胞癌(RCC)治疗中具有一定的发展前景。细胞毒性T淋巴细胞(CTL)是体内杀伤肿瘤的主要效应细胞,如何诱导高效杀伤性CTL成为肿瘤免疫治疗的新课题之一。现就CTL及对RCC治疗的研究进展综述如下。一、CTL的产生和生物学作用
Studies have shown that many immune molecules have some promise in the treatment of renal cell carcinoma (RCC). Cytotoxic T lymphocytes (CTLs) are the major effector cells that kill tumors in vivo. How to induce highly effective cytotoxic T lymphocytes (CTLs) is one of the new topics in tumor immunotherapy. The progress of the research on CTL and RCC are summarized as follows. First, the production of CTL and biological effects